<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <title>Practice 4</title>
    <link rel="stylesheet" href="./style.css" />
  </head>
  <body>
    <section class="center">
      <strong class="title"
        >Table1. Stem Cell Companies Active in Ophthalmology</strong
      >
      <table>
        <thead>
          <tr>
            <th class="company">Company</th>
            <th class="collaborator">Collaborator(s)</th>
            <th class="cell">Cell Type</th>
            <th class="application">Applications</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <th>Advanced Cell Technology Inc. (ACT)</th>
            <td>
              Oregon Health & Science University (OHSU)
              <ul>
                <li>Moorfields Eye Hosp.</li>
                <li>UCLA/Jules Stein</li>
                <li>Wills Eye Hospital</li>
                <li>Aberdeen Royal Infirm.</li>
                <li>Bascom Palmer</li>
              </ul>
            </td>
            <td>hESCs</td>
            <td>
              RPE cells for retinal diseases, including Dry AMD
              <a href="#">NCT01344993</a> and Stargardt's
              <a href="#">NCT01345006</a>
              <a href="#">NCTO1469832</a>
            </td>
          </tr>

          <tr>
            <th>AstraZeneca</th>
            <td>Univ, College London (UCL)</td>
            <td>hESCs</td>
            <td>Diabetic Retinopathy</td>
          </tr>

          <tr>
            <th>Centecor/J&Jw/iScience Interventional</th>
            <td>
              <ul>
                <li>Retina Institude of CA</li>
                <li>Wills Eye Hospital</li>
              </ul>
            </td>
            <td>Adult SCs (CNTO 2746 from umbillical cord fluid)</td>
            <td>
              RPE cells for GA, (atrophic dry AMD)
              <a href="#">NCT01226628</a>
            </td>
          </tr>

          <tr>
            <th>Cell Cure Neurosciences</th>
            <td>TEVA</td>
            <td>hESCs</td>
            <td>RPE cells fro dry AMD</td>
          </tr>

          <tr>
            <th>CellSeed France SARL</th>
            <td>
              <div>FGK Clinical Research GmbH</div>
              <ul>
                <li>Universitatasklinkum, Erlangen, Germany</li>
              </ul>
            </td>
            <td>oral mucosa epithelial cells</td>
            <td>
              CAOMECS* for Corneal tissue repair in those with limbal cell
              deficiencies
              <a href="#">NCT01489501</a>
            </td>
          </tr>

          <tr>
            <th>Fundacion Clinic per a la Recerca Biomedica (Spain)</th>
            <td>
              <ul>
                <li>Hospital Clinic Barcelona</li>
                <li>Instituto Univ. Barraquer</li>
                <li>Instituto de Microcirugia Ocular</li>
              </ul>
            </td>
            <td>sclerocomeal progenitor cells from the limbus</td>
            <td>
              Replacement of damaged corneal cells
              <a href="#">NCT01470573</a>
            </td>
          </tr>

          <tr>
            <th>
              General Hosp of the Chinese People's Armed Police Force (China)
            </th>
            <td></td>
            <td>unknown</td>
            <td>
              Optic Nerve Atrophy
              <a href="#">ChiCTR-TNRC-11001491</a>
            </td>
          </tr>

          <tr>
            <th>International Stem Cell Corp. (ISCO)</th>
            <td>
              <div>CytoCor&nbsp;-</div>
              <ul>
                <li>Absorption Systems - US</li>
                <li>Snakarar Nethralaya - India</li>
                <li>Automation Partnership - UK</li>
              </ul>
              <div>CytoRet - UC Irvine</div>
            </td>
            <td>hpSCs</td>
            <td>Corneal tissue for transplanation int degenerated corneas</td>
          </tr>
        </tbody>
      </table>
    </section>
  </body>
</html>
